The latest price target for Diebold Nixdorf (NYSE: DBD) was reported by DA Davidson on October 24, 2022. The analyst firm set a price target for $3.00 expecting DBD to rise to within 12 months (a possible 36.05% upside). 3 analyst firms have reported ratings in the last year.

The latest analyst rating for Diebold Nixdorf (NYSE: DBD) was provided by DA Davidson, and Diebold Nixdorf downgraded their neutral rating.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Diebold Nixdorf, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Diebold Nixdorf was filed on October 24, 2022 so you should expect the next rating to be made available sometime around October 24, 2023.

While ratings are subjective and will change, the latest Diebold Nixdorf (DBD) rating was a downgraded with a price target of $5.00 to $3.00. The current price Diebold Nixdorf (DBD) is trading at is $2.21, which is out of the analyst's predicted range.